Caricamento...
Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis
Improving understanding of the underlying pathophysiology of giant cell arteritis (GCA) is transforming clinical management by identifying novel avenues for targeted therapies. One key area of concern for both clinicians and patients with GCA is glucocorticoid (GC) morbidity. The first randomised co...
Salvato in:
| Pubblicato in: | Ophthalmol Ther |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513947/ https://ncbi.nlm.nih.gov/pubmed/30820767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-019-0171-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|